Neoantigen Summit, 20-22 Nov in Boston

Oct 25, 2019

CSO Jeroen van Bergen will be presenting key highlights of Immunetune’s preclinical proof-of-concept results at the Neoantigen summit in Boston, USA on November 20-22, 2019.

Immunetune joins the fight against Sars-CoV-2

Immunetune joins the fight against Sars-CoV-2

Within a newly established consortium, Immunetune will develop enhanced DNA vaccines against SARS-CoV-2 and other human coronaviruses. The vaccine is built on the combination of two strong synthetic vaccine platforms and the inclusion of conserved T and B cell...

read more